Intersect Capital’s Labcorp LH Stock Holding History

Intersect Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$321K	Sell	1,596 -688	-30%	-$147K	0.1%	220
2022 Q1	$517K	Buy	2,284 +618	+37%	+$145K	0.1%	188
2021 Q4	$450K	Buy	1,666 +501	+43%	+$124K	0.08%	218
2021 Q3	$282K	Buy	1,165 +308	+36%	+$77.6K	0.05%	292
2021 Q2	$203K	Buy	+857	New	+$195K	0.04%	350
2019 Q3	–	Sell	-1,367	Closed	-$203K	–	175
2019 Q2	$203K	Buy	+1,367	New	+$191K	0.08%	164
2015 Q2	–	Sell	-175	Closed	-$18K	–	247
2015 Q1	$18K	Sell	175 -145	-45%	-$14.9K	0.01%	279
2014 Q4	$30K	Buy	+320	New	+$28.3K	0.03%	237

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Intersect Capital's LH Position: Q2 2022 in Review

Intersect Capital reduced its Labcorp (LH) stake by 30% in Q2 2022, selling an estimated $147K and leaving 1,596 shares worth $321K. The position accounts for 0.1% of the portfolio, ranked #220.

Intersect Capital first reported a position in LH in Q4 2014 and has held it in 8 quarters since. The position peaked at $517K in Q1 2022. 966 funds tracked by Wall St. Rank hold LH as of Q2 2022.

Intersect Capital held 1,596 shares of Labcorp worth $321K as of Q2 2022.
Intersect Capital sold 688 Labcorp shares in Q2 2022, an estimated $147K.
Labcorp made up 0.1% of Intersect Capital's portfolio in Q2 2022, its #220 holding.
Intersect Capital first reported a position in Labcorp in Q4 2014 and has held it in 8 quarters since.
Intersect Capital's Labcorp position peaked at $517K in Q1 2022.
966 funds tracked by Wall St. Rank held Labcorp as of Q2 2022.

Based on Intersect Capital's 13F filing for Q2 2022, filed 2 Sep 2022.